Patients on long-term zidovudine (AZT) therapy experience muscle fatigue and weakness attributed to AZT-induced mitochondrial toxicity in skeletal muscle. To determine if the clinico-pathological abnormalities in these patients correspond to abnormal muscle energy metabolism, we used 31P in vivo magnetic resonance spectroscopy to follow phosphorylated metabolites during exercise. We studied 19 normal volunteers, 6 HIV-positive patients never treated with AZT, and 9 HIV-positive patients who had been treated with AZT for a mean period of 33 mo (range 12-48 mo) and had muscle biopsy-proven AZT-myopathy with abnormal mitochondria. Changes in phosphocreatine, ATP, and intracellular pH in the gastrocnemius muscle were followed during a graded steady state exercise protocol, and the recovery of phosphocreatine was followed on cessation of exercise. We found that graded steady state exercise produced a greater depletion of muscle phosphocreatine levels in the AZT-treated patients, compared to either HIV-positive patients who were not treated with AZT or normal controls. No differences in the effects of steady state exercise on muscle phosphocreatine levels were observed between the control group and the HIV-positive patients who had not been treated with AZT. The results suggest that the effect of AZT on muscle energy metabolism is significant, and similar to the effect observed in patients with known mitochondrial myopathies. Using a well-known model for control of mitochondrial metabolism, the observed differences in steady state phosphocreatine levels during exercise suggest that AZT treatment decreases the maximal work output and the maximal rate of muscle ATP synthesis.
T M Sinnwell, K Sivakumar, S Soueidan, C Jay, J A Frank, A C McLaughlin, M C Dalakas
Title and authors | Publication | Year |
---|---|---|
Muscle Toxicity of Drugs: When Medication Turns Physiology into Pathophysiology
L Janssen, N Allard, C Saris, J Keijer, MT Hopman, S Timmers |
Physiological reviews | 2019 |
Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial
H Makimura, TL Stanley, C Suresh, AL de Sousa-Coelho, WR Frontera, S Syu, LR Braun, SE Looby, MN Feldpausch, M Torriani, H Lee, ME Patti, SK Grinspoon |
The Journal of clinical endocrinology and metabolism | 2016 |
Skeletal muscle cellular metabolism in older HIV‐infected men
HK Ortmeyer, AS Ryan, C HaferMacko, KA Oursler |
Physiological Reports | 2016 |
Heteronuclear complexes of phosphocreatine with copper(II) and magnesium(II) ions
R Jastrzab, M Nowak, M Zabiszak |
Journal of the Iranian Chemical Society | 2014 |
In Vivo Mitochondrial Function in HIV-Infected Persons Treated with Contemporary Anti-Retroviral Therapy: A Magnetic Resonance Spectroscopy Study
BA Payne, KG Hollingsworth, J Baxter, E Wilkins, V Lee, DA Price, M Trenell, PF Chinnery, RJ Wilkinson |
PloS one | 2014 |
Effect of Zidovudine and its interaction with rocuronium on neuromuscular transmission
MJ Barvaliya, TK Patel, JC Patel, CB Tripathi |
Indian journal of pharmaceutical sciences | 2013 |
Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro
U Gandapu, RK Chaitanya, G Kishore, RC Reddy, AK Kondapi, M Antopolsky |
PloS one | 2011 |
Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action:
C Bazzoli, V Jullien, CL Tiec, E Rey, F Mentré, AM Taburet |
Clinical Pharmacokinetics | 2010 |
Mitochondrial Function and Insulin Resistance in Overweight and Normal-Weight Children
A Fleischman, M Kron, DM Systrom, M Hrovat, SK Grinspoon |
The Journal of clinical endocrinology and metabolism | 2009 |
Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
GK Sakkas, K Mulligan, M DaSilva, JW Doyle, H Khatami, T Schleich, JA Kent-Braun, M Schambelan, G Parise |
PloS one | 2009 |
In vivo assessment of mitochondrial toxicity
BF Hamilton, AH Stokes, J Lyon, RR Adler |
Drug Discovery Today | 2008 |
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend |
Side Effects of Drugs Annual | 2007 |
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults
A Fleischman, S Johnsen, DM Systrom, M Hrovat, CT Farrar, W Frontera, K Fitch, BJ Thomas, M Torriani, HC Côté, SK Grinspoon |
American journal of physiology. Endocrinology and metabolism | 2007 |
Zidovudine Inhibits Thymidine Phosphorylation in the Isolated Perfused Rat Heart
D Susan-Resiga, AT Bentley, MD Lynx, DD LaClair, EE McKee |
Antimicrobial agents and chemotherapy | 2007 |
3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria
MD Lynx, EE McKee |
Biochemical Pharmacology | 2006 |
3'-Azido-3'-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: a possible mechanism of AZT hepatotoxicity
MD Lynx, AT Bentley, EE McKee |
Biochemical Pharmacology | 2006 |
Mitochondrial Toxicity in FetalErythrocebus patasMonkeys Exposed Transplacentally to Zidovudine Plus Lamivudine
M Gerschenson, V Nguyen, EL Ewings, A Ceresa, JA Shaw, MC st. Claire, K Nagashima, SW Harbaugh, JW Harbaugh, OA Olivero, RL Divi, PS Albert, MC Poirier |
AIDS Research and Human Retroviruses | 2004 |
Aerobic Exercise Dysfunction in Human Immunodeficiency Virus: A Potential Link to Physical Disability
WT Cade, L Peralta, RE Keyser |
Physical therapy | 2004 |
Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions
W Lewis |
Antiviral Research | 2003 |
Decreased peak arteriovenous oxygen difference during treadmill exercise testing in individuals infected with the human immunodeficiency virus
WT Cade, LE Fantry, SR Nabar, RE Keyser |
Archives of Physical Medicine and Rehabilitation | 2003 |
Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy
W Lewis |
Progress in Cardiovascular Diseases | 2003 |
Drug-induced and toxic myopathies
S Guis, JP Mattéi, F Lioté |
Best Practice & Research Clinical Rheumatology | 2003 |
Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
W Lewis, BJ Day, WC Copeland |
Nature Reviews Drug Discovery | 2003 |
Impaired glucose phosphorylation and transport in skeletal muscle causes insulin resistance in HIV-1 infected patients with lipodystrophy
Georg M.N. Behrens, Anne-Rose Boerner, Klaus Weber, Joerg van den Hoff, Johann Ockenga, Georg Brabant, Reinhold E. Schmidt |
Journal of Clinical Investigation | 2002 |
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients
HC Côté, ZL Brumme, KJ Craib, CS Alexander, B Wynhoven, L Ting, H Wong, M Harris, PR Harrigan, MV O'Shaughnessy, JS Montaner |
New England Journal of Medicine | 2002 |
Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?
T Dagan, C Sable, J Bray, M Gerschenson |
Mitochondrion | 2002 |
Mitochondrial DNA Depletion, Oxidative Stress, and Mutation: Mechanisms 0f Dysfunction from Nucleoside Reverse Transcriptase Inhibitors
W Lewis, WC Copeland, BJ Day |
Laboratory Investigation | 2001 |
Rheumatic manifestations of current pharmacopeia
J Brenner, BM Solitar, BD Golden |
Current Rheumatology Reports | 2000 |
Fetal Mitochondrial Heart and Skeletal Muscle Damage inErythrocebus patasMonkeys Exposedin Uteroto 3'-Azido-3'-Deoxythymidine
M Gerschenson, SW Erhart, CY Paik, MC st. Claire, K Nagashima, B Skopets, SW Harbaugh, JW Harbaugh, W Quan, MC Poirier |
AIDS Research and Human Retroviruses | 2000 |
Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells
XR Pan-Zhou, L Cui, XJ Zhou, JP Sommadossi, VM Darley-Usmar |
Antimicrobial agents and chemotherapy | 2000 |
Functional aerobic impairment in adolescents seropositive for HIV: A quasiexperimental analysis
RE Keyser, L Peralta, WT Cade, S Miller, J Anixt |
Archives of Physical Medicine and Rehabilitation | 2000 |
The Fatigue Experience for Women With Human Immunodeficiency Virus
KA Lee, CJ Portillo, H Miramontes |
Journal of Obstetric, Gynecologic, & Neonatal Nursing | 1999 |
A Review of Fatigue in People With HIV Infection
J Barroso |
Journal of the Association of Nurses in AIDS care | 1999 |
Mitochondria as Cell Targets of AZT (Zidovudine)
M Barile, D Valenti, E Quagliariello, S Passarella |
General Pharmacology: The Vascular System | 1998 |
3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator
M Barile |
Biochemical Pharmacology | 1997 |
Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation
A Elimadi, D Morin, E Albengres, AM Chauvet-Monges, V Allain, A Crevat, JP Tillement |
British Journal of Pharmacology | 1997 |
Normalized metabolic stress for 31 P-MR spectroscopy studies of human skeletal muscle: MVC vs. muscle volume
MD Fowler, TW Ryschon, RE Wysong, CA Combs, RS Balaban |
Journal of applied physiology | 1997 |